BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29943355)

  • 1. Establishment and characterization of novel patient-derived osteosarcoma xenograft and cell line.
    Kito F; Oyama R; Sakumoto M; Takahashi M; Shiozawa K; Qiao Z; Sakamoto H; Hirose T; Setsu N; Yoshida A; Kawai A; Kondo T
    In Vitro Cell Dev Biol Anim; 2018 Aug; 54(7):528-536. PubMed ID: 29943355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and characterization of patient-derived xenograft and its cell line of primary leiomyosarcoma of bone.
    Oyama R; Takahashi M; Kito F; Sakumoto M; Shiozawa K; Qiao Z; Yoshida A; Endo M; Kawai A; Kondo T
    In Vitro Cell Dev Biol Anim; 2018 Jun; 54(6):458-467. PubMed ID: 29845452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a patient-derived orthotopic osteosarcoma mouse model.
    Blattmann C; Thiemann M; Stenzinger A; Roth EK; Dittmar A; Witt H; Lehner B; Renker E; Jugold M; Eichwald V; Weichert W; Huber PE; Kulozik AE
    J Transl Med; 2015 Apr; 13():136. PubMed ID: 25926029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, NCC-dCS1-C1.
    Oyama R; Kito F; Takahashi M; Sakumoto M; Shiozawa K; Qiao Z; Noguchi R; Kubo T; Toki S; Nakatani F; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2019 Apr; 32(2):202-213. PubMed ID: 30737713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative proteome analysis of monolayer and spheroid culture of canine osteosarcoma cells.
    Gebhard C; Miller I; Hummel K; Neschi Née Ondrovics M; Schlosser S; Walter I
    J Proteomics; 2018 Apr; 177():124-136. PubMed ID: 29337282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic approach toward molecular backgrounds of drug resistance of osteosarcoma cells in spheroid culture system.
    Arai K; Sakamoto R; Kubota D; Kondo T
    Proteomics; 2013 Aug; 13(15):2351-60. PubMed ID: 23712969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and proteomic characterization of a novel cell line, NCC-UPS2-C1, derived from a patient with undifferentiated pleomorphic sarcoma.
    Oyama R; Kito F; Sakumoto M; Shiozawa K; Toki S; Yoshida A; Kawai A; Kondo T
    In Vitro Cell Dev Biol Anim; 2018 Mar; 54(3):257-263. PubMed ID: 29359268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and proteomic characterization of patient-derived clear cell sarcoma xenografts and cell lines.
    Sakumoto M; Oyama R; Takahashi M; Takai Y; Kito F; Shiozawa K; Qiao Z; Endo M; Yoshida A; Kawai A; Kondo T
    In Vitro Cell Dev Biol Anim; 2018 Feb; 54(2):163-176. PubMed ID: 29197033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and characterization of novel patient-derived extraskeletal osteosarcoma cell line NCC-ESOS1-C1.
    Kito F; Oyama R; Noguchi R; Hattori E; Sakumoto M; Endo M; Kobayashi E; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2020 Jan; 33(1):283-290. PubMed ID: 31625124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and characterization of in vivo orthotopic bioluminescent xenograft models from human osteosarcoma cell lines in Swiss nude and NSG mice.
    Marques da Costa ME; Daudigeos-Dubus E; Gomez-Brouchet A; Bawa O; Rouffiac V; Serra M; Scotlandi K; Santos C; Geoerger B; Gaspar N
    Cancer Med; 2018 Mar; 7(3):665-676. PubMed ID: 29473324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of a novel cell line, NCC-MFS1-C1, derived from a patient with myxofibrosarcoma.
    Kito F; Oyama R; Sakumoto M; Shiozawa K; Qiao Z; Toki S; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2019 Apr; 32(2):214-222. PubMed ID: 30737712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and characteristics of two syngeneic human osteosarcoma cell lines from primary tumor and skip metastases.
    Zou CY; Wang J; Shen JN; Huang G; Jin S; Yin JQ; Guo QC; Li HM; Luo L; Zhang M; Zhang LJ
    Acta Pharmacol Sin; 2008 Mar; 29(3):325-32. PubMed ID: 18298897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1.
    Oyama R; Kito F; Sakumoto M; Shiozawa K; Toki S; Endo M; Yoshida A; Kawai A; Kondo T
    In Vitro Cell Dev Biol Anim; 2018 May; 54(5):392-399. PubMed ID: 29626278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo antitumor effects of the VO-chrysin complex on a new three-dimensional osteosarcoma spheroids model and a xenograft tumor in mice.
    León IE; Cadavid-Vargas JF; Resasco A; Maschi F; Ayala MA; Carbone C; Etcheverry SB
    J Biol Inorg Chem; 2016 Dec; 21(8):1009-1020. PubMed ID: 27696106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ErbB3 silencing reduces osteosarcoma cell proliferation and tumor growth in vivo.
    Jullien N; Dieudonné FX; Habel N; Marty C; Modrowski D; Patino A; Lecanda F; Sévère N; Marie PJ
    Gene; 2013 May; 521(1):55-61. PubMed ID: 23541807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of autophagy-related protein 6, Beclin-1, decreases cell growth, invasion, and metastasis and has a positive effect on chemotherapy-induced cytotoxicity in osteosarcoma cells.
    Zhang W; Li Q; Song C; Lao L
    Tumour Biol; 2015 Apr; 36(4):2531-9. PubMed ID: 25427639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA tumor suppressor candidate 7 functions as a tumor suppressor and inhibits proliferation in osteosarcoma.
    Cong M; Li J; Jing R; Li Z
    Tumour Biol; 2016 Jul; 37(7):9441-50. PubMed ID: 26781978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking Tumor-Educated MSC Paracrine Activity Halts Osteosarcoma Progression.
    Baglio SR; Lagerweij T; Pérez-Lanzón M; Ho XD; Léveillé N; Melo SA; Cleton-Jansen AM; Jordanova ES; Roncuzzi L; Greco M; van Eijndhoven MAJ; Grisendi G; Dominici M; Bonafede R; Lougheed SM; de Gruijl TD; Zini N; Cervo S; Steffan A; Canzonieri V; Martson A; Maasalu K; Köks S; Wurdinger T; Baldini N; Pegtel DM
    Clin Cancer Res; 2017 Jul; 23(14):3721-3733. PubMed ID: 28053020
    [No Abstract]   [Full Text] [Related]  

  • 19. A novel peptide targets CD105 for tumour imaging in vivo.
    Li X; Huang X; Zhang J; Huang H; Zhao L; Yu M; Zhang Y; Wang H
    Oncol Rep; 2018 Nov; 40(5):2935-2943. PubMed ID: 30132552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-96 acts as a tumor suppressor gene in human osteosarcoma via target regulation of EZRIN.
    Yao Q; Pei Y; Zhang X; Xie B
    Life Sci; 2018 Jun; 203():1-11. PubMed ID: 29656060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.